Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on March 25, 2025
CIRRO Fulfillment integrates with Pipe17 to enhance e-commerce operations
GlobeNewswire
·
March 25, 2025
MONROE TOWNSHIP, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- CIRRO Fulfillment, a leading global e-commerce fulfillment provider, announces its integration with Pipe17, an AI-native Order Operations platform. This partnership enhances automation, real-time …
Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System
GlobeNewswire
·
March 25, 2025
Lausanne, Switzerland, March 25, 2025 (GLOBE NEWSWIRE) -- Distalmotion announces that it completed the first US sale and delivery of the DEXTER Robotic Surgery System to Memorial Hermann Health System in Houston, Texas in early February. This milestone …
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
GlobeNewswire
·
March 25, 2025
Helicore’s first-in-human study is designed to evaluate the safety and tolerability of HCR-188 in a single and multiple ascending dose study Top-line safety data anticipated in the second half of 2025 SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE …
GoldHaven Mobilizes Exploration at Copeçal Gold Project in Brazil
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce the engagement of Gustavo Rosa de Almeida (M.Sc.) as the local project …
Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference
GlobeNewswire
·
March 25, 2025
AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), ”), a leader in RNA-based therapeutics, announced today the successful completion of a Phase 1 clinical trial …
Helius Minerals Announces Non-Brokered Private Placement to Raise up to Cdn$2,150,000
GlobeNewswire
·
March 25, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Helius Minerals Limited (“Helius” or the “Company”) (TSXV: HHH) is pleased to announce that it is arranging …
NervGen Pharma to Host Virtual Investor Event
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that it will host a virtual investor …
Aprea Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
GlobeNewswire
·
March 25, 2025
ACESOT-1051 trial evaluating WEE1 kinase inhibitor APR-1051 now enrolling patients in Cohort 5; open label safety and efficacy data expected H2 2025 Twice daily (BID) dosing regimen in ongoing ABOYA-119 trial expected to maximize clinical benefit of ATR …
New research showcases Wolters Kluwer’s expert solutions journey
GlobeNewswire
·
March 25, 2025
PRESS RELEASE New research showcases Wolters Kluwer’s expert solutions journey The working paper by MIT CISR explores Wolters Kluwer’s transformation from publisher to global expert solutions provider NEW YORK – March 25, 2025 – Researchers from the …
XRP News: Why Investors Are Rushing Into XploraDEX $XPL Presale – The Only AI-Powered DEX on XRP Ledger
GlobeNewswire
·
March 25, 2025
ZURICH, March 25, 2025 (GLOBE NEWSWIRE) -- In the fast-paced world of crypto, early access to innovation often defines who wins big. That’s why XploraDEX is quickly becoming one of the most talked-about projects on the XRP Ledger. As the first and only AI- …
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
GlobeNewswire
·
March 25, 2025
PRINCETON, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Latin Metals Secures Drill Permits for Cerro Bayo Silver-Gold Project, Argentina
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce a major milestone in the advancement of its Cerro Bayo Project ("Cerro Bayo" or the " …
Global Li-Ion secures processing plant near Ambato Arana Graphite mine.
GlobeNewswire
·
March 25, 2025
Vancouver, British Columbia, Canada, March 25, 2025 (GLOBE NEWSWIRE) -- Global Li-Ion Graphite Corp. (“Global Li-Ion” or, the “Company”) (CSE: LION, OTCQB: GBBGF, F: 0TD) is pleased to announce it has secured the processing plant that processed the ore …
Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial
GlobeNewswire
·
March 25, 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
GlobeNewswire
·
March 25, 2025
HAYWARD, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed …
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 25, 2025
‒ Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm ‒ ‒ Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- …
Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
GlobeNewswire
·
March 25, 2025
Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic Dermatitis Third Quoin Patent Application for Netherton Syndrome If Granted Company Would have Patent Protection for QRX003 for Netherton …
L’usine pilote du Réacteur de Silice Pyrogénée de HPQ atteint son premier jalon important, la validation morphologique des matériaux
GlobeNewswire
·
March 25, 2025
MONTRÉAL, 25 mars 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l'ingénierie verte souhaite informer ses actionnaires d’un jalon important franchi …
BTCC Exchange Enhances VIP Program to Empower High-Volume Traders Worldwide
GlobeNewswire
·
March 25, 2025
Vilnius, Lithuania, March 25, 2025 (GLOBE NEWSWIRE) -- BTCC, one of the world’s longest-serving cryptocurrency exchanges, is thrilled to announce a significant revamp of its VIP program, specifically designed to cater to high-volume traders among its 6.8 …
HPQ Fumed Silica Reactor Pilot Plant Achieves First Important Morphological Validation Milestone
GlobeNewswire
·
March 25, 2025
MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering of processes would like to update shareholders on an important milestone …